GC Pharma to Establish Curevo – a Seattle-based New Company Dedicated to Development of New Vaccines
YONGIN, South Korea, May 20, 2018 /PRNewswire/ — GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced the establishment of Curevo Inc. (“Curevo”). The newly established Seattle-based company’s goal is to support GC Pharma’s vaccine development activities.
GC Pharma builds a strategic collaboration and partnership with global health organizations IDRI (Infectious Disease Research Institute) and MIBR (Mogam Institute for Biomedical Research) to form the new company.
Read the full article published by GC Pharma.